Alessia Cucci
Overview
Explore the profile of Alessia Cucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Honarpisheh M, Lei Y, Follenzi A, Cucci A, Olgasi C, Berishvili E, et al.
Cells
. 2025 Mar;
14(5).
PMID: 40072094
The engraftment of transplanted islets depends on the rapid establishment of a novel vascular network. The present study evaluated the effects of cord blood-derived blood outgrowth endothelial cells (BOECs) on...
2.
Sgromo C, Cucci A, Venturin G, Follenzi A, Olgasi C
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769040
Endothelial cells (ECs) are crucial for vascular health, regulating blood flow, nutrient exchange, and modulating immune responses and inflammation. The impairment of these processes causes the endothelial dysfunction (ED) characterized...
3.
Olgasi C, Cucci A, Molineris I, Assanelli S, Anselmi F, Borsotti C, et al.
Haematologica
. 2024 Jun;
109(10):3391-3397.
PMID: 38841804
No abstract available.
4.
Tonetto E, Cucci A, Follenzi A, Bernardi F, Pinotti M, Balestra D
J Thromb Haemost
. 2024 May;
22(8):2171-2183.
PMID: 38718928
Background: Replacement and nonreplacement therapies effectively control bleeding in hemophilia A (HA) but imply lifelong interventions. Authorized gene addition therapy could provide a cure but still poses questions on durability....
5.
Olgasi C, Assanelli S, Cucci A, Follenzi A
Haematologica
. 2024 Mar;
109(7):2041-2048.
PMID: 38426281
Hemostasis is a sophisticated sequence of events aimed at repairing vessel injury. This process occurs in combination with angiogenesis, which leads to new blood vessel formation, helping in wound repair...
6.
Mannarino M, Bianconi V, Scalisi G, Franceschini L, Manni G, Cucci A, et al.
Front Immunol
. 2023 Apr;
14:964660.
PMID: 37081894
Background: Chronic systemic inflammation reduces the bioavailability of circulating endothelial progenitor cells (EPCs). Indoleamine 2,3-dioxygenase 1 (IDO1), a key enzyme of immune tolerance catalyzing the initial step of tryptophan degradation...
7.
Citro A, Neroni A, Pignatelli C, Campo F, Policardi M, Monieri M, et al.
Nat Commun
. 2023 Feb;
14(1):878.
PMID: 36797282
Intrahepatic islet transplantation is the standard cell therapy for β cell replacement. However, the shortage of organ donors and an unsatisfactory engraftment limit its application to a selected patients with...
8.
Olgasi C, Borsotti C, Merlin S, Bergmann T, Bittorf P, Adewoye A, et al.
Mol Ther Methods Clin Dev
. 2021 Dec;
23:551-566.
PMID: 34853801
Hemophilia A (HA) is a rare bleeding disorder caused by deficiency/dysfunction of the FVIII protein. As current therapies based on frequent FVIII infusions are not a definitive cure, long-term expression...
9.
Fanelli A, Vannelli S, Babu D, Mellone S, Cucci A, Monzani A, et al.
Mol Genet Genomic Med
. 2021 Nov;
10(1):e1793.
PMID: 34811950
Background: SHOX enhancer CNVs, affecting one or more of the seven recognized evolutionary conserved non-coding elements (CNEs) represent one of the most frequent cause of SHOX-haploinsufficiency. During the diagnostic workflow...
10.
Olgasi C, Cucci A, Follenzi A
Int J Mol Sci
. 2020 Sep;
21(17).
PMID: 32867371
Liver transplantation is the most common treatment for patients suffering from liver failure that is caused by congenital diseases, infectious agents, and environmental factors. Despite a high rate of patient...